Cargando…

High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma

The function of human augmin complex unit 3(Haus3), a component of the HAU augmin-like complex, in various cancers is not clear. This study aims to elucidate the clinical significance and the role of Haus3 in tumor progression of hepatocellular carcinoma (HCC). We analyzed the expression of Haus3 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xuanyu, Zhuang, Runzhou, Ye, Qianwei, Zhuo, Jianyong, Chen, Kangchen, Lu, Di, Wei, Xuyong, Xie, Haiyang, Xu, Xiao, Zheng, Shusen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485217/ https://www.ncbi.nlm.nih.gov/pubmed/31031853 http://dx.doi.org/10.7150/jca.28317

Ejemplares similares

CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
por: Zhuang, Runzhou, et al.
Publicado: (2017)

Molecular architecture of the augmin complex
por: Gabel, Clinton A., et al.
Publicado: (2022)

LEPREL1 Expression in Human Hepatocellular Carcinoma and Its Suppressor Role on Cell Proliferation
por: Wang, Jianguo, et al.
Publicado: (2013)

Catching augmin in the act
por: Leslie, Mitch
Publicado: (2013)

Phosphorylation of PED/PEA-15 at Ser116 and phosphorylation of p27 at Thr187 indicates a poor prognosis in hepatocellular carcinoma
por: Wu, Yifeng, et al.
Publicado: (2021)

Augmin-ting the central spindle
por: Short, Ben
Publicado: (2010)

Integrated model of the vertebrate augmin complex
por: Travis, Sophie M., et al.
Publicado: (2023)

Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy
por: Xu, Shengjun, et al.
Publicado: (2021)

Donor PPARα Gene Polymorphisms Influence the Susceptibility to Glucose and Lipid Disorders in Liver Transplant Recipients: A Strobe-Compliant Observational Study
por: Ling, Qi, et al.
Publicado: (2015)

Diagnostic Value of Preoperative Needle Biopsy for Tumor Grading Assessment in Hepatocellular Carcinoma
por: Wang, Lijun, et al.
Publicado: (2015)

Identification of the Augmin Complex in the Filamentous Fungus Aspergillus nidulans
por: Edzuka, Tomoya, et al.
Publicado: (2014)

Augmin-dependent microtubule nucleation at microtubule walls in the spindle
por: Kamasaki, Tomoko, et al.
Publicado: (2013)

Structural insights into how augmin augments the mitotic spindle
por: Manka, Szymon W.
Publicado: (2023)

Augmin is a Ran-regulated spindle assembly factor
por: Kraus, Jodi, et al.
Publicado: (2023)

The augmin complex architecture reveals structural insights into microtubule branching
por: Zupa, Erik, et al.
Publicado: (2022)

Differing requirements for Augmin in male meiotic and mitotic spindle formation in Drosophila
por: Savoian, Matthew S., et al.
Publicado: (2014)

Augmin shapes the anaphase spindle for efficient cytokinetic furrow ingression and abscission
por: Uehara, Ryota, et al.
Publicado: (2016)

A prognostic model based on the Augmin family genes for LGG patients
por: Wang, Tao, et al.
Publicado: (2023)

High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Huang, Yu, et al.
Publicado: (2018)

Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma
por: Wei, Qiang, et al.
Publicado: (2016)

Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
por: Luo, Rongzhen, et al.
Publicado: (2013)

Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017)

The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
por: Zhuo, Jianyong, et al.
Publicado: (2021)

Mechanism of how augmin directly targets the γ-tubulin ring complex to microtubules
por: Song, Jae-Geun, et al.
Publicado: (2018)

Augmin accumulation on long-lived microtubules drives amplification and kinetochore-directed growth
por: David, Ana F., et al.
Publicado: (2019)

Augmin-dependent microtubule self-organization drives kinetochore fiber maturation in mammals
por: Almeida, Ana C., et al.
Publicado: (2022)

Augmin prevents merotelic attachments by promoting proper arrangement of bridging and kinetochore fibers
por: Štimac, Valentina, et al.
Publicado: (2022)

Microtubule binding of the human augmin complex is directly controlled by importins and Ran-GTP
por: Ustinova, Kseniya, et al.
Publicado: (2023)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma()()
por: Fu, Jia, et al.
Publicado: (2015)

Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinoma
por: Yi, Peng Sheng, et al.
Publicado: (2018)

Linc00511 Indicates A Poor Prognosis Of Liver Hepatocellular Carcinoma
por: Hu, Pingan, et al.
Publicado: (2019)

Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts
por: Zhuo, Jianyong, et al.
Publicado: (2021)

Augmin: a protein complex required for centrosome-independent microtubule generation within the spindle
por: Goshima, Gohta, et al.
Publicado: (2008)

Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1
por: Ling, Sunbin, et al.
Publicado: (2017)

The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma
por: Lu, Di, et al.
Publicado: (2020)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma
por: Shen, Zhenghai, et al.
Publicado: (2017)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_403fnf8185vc8pni61b50to3an